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============================================================

A Published-Ahead-of-Print version of this article was made available online at <http://adisonline.com/druginvestigation/toc/publishahead> on 28 November 2012. An error was subsequently identified in that version of the article, and the following correction should be noted:

**Section 4, paragraph 6, line 4**, which previously read:

"Ciclosporin^®^ is currently being investigated as pharmacological therapy in patients undergoing intervention treatment after myocardial infarction (the CIRCUS Phase III study, "Cyclosporine and Prognosis in Acute Myocardial Infarction \[MI\] Patients", clinicaltrials.gov identifier NCT01502774)."

Should read:

"CicloMulsion^®^ is currently being investigated as pharmacological therapy in patients undergoing intervention treatment after myocardial infarction (the CIRCUS Phase III study, "Cyclosporine and Prognosis in Acute Myocardial Infarction \[MI\] Patients", clinicaltrials.gov identifier NCT01502774)."

The online version of the original article can be found under doi:10.1007/s40261-012-0029-x.
